Aarti Surfactants shareholders approve MOA amendment to widen business scope
AARTISURF · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.1 pts less than Nifty Microcap 250 and 0.5 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
At the 8th AGM held on September 29, 2026, shareholders approved an amendment to the Main Object Clause of the company's Memorandum of Association. The amendment broadens the company's permitted business activities to include pharmaceuticals, bulk drugs, biological and biochemical products, agrochemicals, petrochemicals, and other allied chemical segments beyond surfactants. The altered MOA will be filed after receiving approval from the appropriate regulatory authorities.
Signals diversification intent into pharma and allied chemicals. No immediate financial impact; awaits regulatory clearance.